Cybin Inc., operating commercially as Helus Pharma, announced the appointment of Regina Donohue as Chief People Officer and Suresh Durgam, M.D., to its Scientific Advisory Board. Donohue previously served as Chief Human Resources Officer at Intra-Cellular Therapies, where she scaled the organization through commercialization before its acquisition by Johnson & Johnson in April 2025. Dr. Durgam brings over two decades of CNS drug development experience, having served as Executive Vice President and Chief Medical Officer at Intra-Cellular and played a pivotal role in securing FDA approvals for CAPLYTA. These appointments support Helus Pharma’s growth and preparation for potential commercialization of its proprietary serotonergic agonists pipeline, including HLP003 and HLP004. The company operates in the pharmaceutical industry, developing novel treatments for mental health conditions.
